首页> 美国卫生研究院文献>PLoS Neglected Tropical Diseases >Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase
【2h】

Protective immune responses against Schistosoma mansoni infection by immunization with functionally active gut-derived cysteine peptidases alone and in combination with glyceraldehyde 3-phosphate dehydrogenase

机译:通过单独使用功能活性肠源性半胱氨酸肽酶并结合甘油醛3-磷酸脱氢酶进行免疫接种以抵抗曼氏血吸虫感染的保护性免疫应答

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundSchistosomiasis, a severe disease caused by parasites of the genus Schistosoma, is prevalent in 74 countries, affecting more than 250 million people, particularly children. We have previously shown that the Schistosoma mansoni gut-derived cysteine peptidase, cathepsin B1 (SmCB1), administered without adjuvant, elicits protection (>60%) against challenge infection of S. mansoni or S. haematobium in outbred, CD-1 mice. Here we compare the immunogenicity and protective potential of another gut-derived cysteine peptidase, S. mansoni cathepsin L3 (SmCL3), alone, and in combination with SmCB1. We also examined whether protective responses could be boosted by including a third non-peptidase schistosome secreted molecule, glyceraldehyde 3-phosphate dehydrogenase (SG3PDH), with the two peptidases.
机译:背景血吸虫病是一种由血吸虫属寄生虫引起的严重疾病,在74个国家中普遍存在,影响了超过2.5亿人,尤其是儿童。我们以前已经证明,曼氏血吸虫肠源性半胱氨酸肽酶组织蛋白酶B1(SmCB1)在没有佐剂的情况下给予了保护(> 60%),以抵抗异型CD-1小鼠中曼氏沙门氏菌或血生沙门氏菌的挑战性感染。在这里,我们比较了另一种肠道来源的半胱氨酸肽酶S. mansoni组织蛋白酶L3(SmCL3)单独和与SmCB1组合的免疫原性和保护潜力。我们还检查了是否可以通过将第三个非肽酶血吸虫分泌分子,甘油醛3-磷酸脱氢酶(SG3PDH)包括在两个肽酶中来增强保护反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号